DBD

Dược - Trang thiết bị Y tế Bình Định (Bidiphar) ·HOSE ·2026Q1

▼ Slightly negative

Working capital is tied up too long in the operating cycle Working capital 218 days
Price
51,400
Latest close
03 Jun 2026
P/E 16.70x
P/B 2.67x
EPS 3,078
BVPS 19,219
ROE 16.3%
ROA 11.8%
Profit Margin 15.5%
Asset Turnover 0.76x
Equity Mult. 1.38x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DBD is maintaining revenue, but margins are compressing slightly — profit is at an all-time high. What remains unclear is whether this is a short-term fluctuation or costs are starting to outpace revenue.

TTM REVENUE
VND 1,872bn
+4.9%YoY
NET MARGIN
15.49%
−0.7ppYoY
TTM NET PROFIT
VND 290bn
+0.3%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 448.1 510.0 439.7 474.5 441.0 477.9 432.8 433.1 383.8 444.5 411.4 414.1
Growth -12% +16% -7% +8% -8% +10% -0% +13% -14% +8% -1%
Net Income 80.3 59.5 59.9 90.3 81.0 60.6 75.0 72.4 67.1 59.2 67.2 71.8
Net Margin 17.92% 11.67% 13.63% 19.04% 18.37% 12.69% 17.33% 16.72% 17.50% 13.31% 16.34% 17.35%

Drivers of DBD's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower selling expenses. Supporting and offsetting drivers:

Selling expenses ↓ 30.2bn
Financial income ↑ 14.1bn
Other profit ↑ 3.7bn
Finance costs ↓ 1.5bn
Administrative expenses ↑ 20.2bn
Gross profit ↓ 14.7bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:

Administrative expenses ↓ 25.3bn
Financial income ↑ 3.5bn
Associates income ↑ 1.7bn
Other profit ↑ 1.3bn
Gross profit ↓ 24.3bn
Selling expenses ↑ 7.5bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 17.9% = 16.2% × 0.85 × 1.31
2026Q1 16.3% = 15.5% × 0.76 × 1.38

ROE fell from 17.9% to 16.3% — asset turnover weakened the most, though leverage still provided support.

Net margin: 15.5% -0.7pp Asset turnover: 0.76x -0.08x Leverage: 1.38x +0.08x

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

very positive positive stable watch under pressure

What is driving the margin?

Net margin narrowed to 15.49%, falling 0.7pp. The main pressure is Gross margin fell 3.1pp, outweighing the improvement in SG&A / Revenue fell 2.0pp (with additional support from Net financial result / Revenue rose 0.8pp and Other profit / Revenue rose 0.2pp).

Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.

Profitability trend

Net Margin 15.49% −0.7pp
Gross Margin 45.80% −3.1pp
SG&A / Revenue 28.81% −2.0pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

ROIC fell to 16.78%, losing 2.7pp. That translates to 16.78 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 0.9pp and capital turnover fell 0.11x, while invested capital rose by 233bn — pressure came from both operational efficiency and asset efficiency.

Both margin and turnover weakened — this is a broad-based decline, and cyclical versus structural components need to be separated.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 16.78% −2.7pp
NOPAT Margin 15.57% −0.9pp
Capital Turnover 1.08x −0.11x
Average Invested Capital 1,736.8bn +232.9bn

Balance Sheet

ROIC declined — the balance sheet shows how capital is being deployed. Capital structure is conservative with low leverage — liabilities at 0.50x equity, net debt at 0.08x equity.

Inventory ended the period at 366.1bn, roughly 14.1% of total assets.

Over the last 12 months, working capital released 168.9bn of cash, mainly thanks to lower inventories and higher payables. Pressure from higher receivables only partly offset that benefit.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −10.0bn
Inventories decreased → higher CFO: +41.3bn
Payables increased → higher CFO: +137.6bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 41.0 days versus the same period last year. The main moves came from DIO fell 26.6 days, DSO fell 1.5 days, and DPO rose 12.8 days.

All 3 drivers (collection, inventory, payables) are improving — working capital turnover is strengthening across the board.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 217.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 101.0 days −1.5 days
Inventory 169.8 days −26.6 days
Payables 52.9 days +12.8 days
Cash Conversion Cycle 217.9 days −41.0 days

Is financial risk significant?

Financial risk is low — leverage is safe, both CFO and FCF are positive.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.08x and interest coverage at 22.89x.

At present, short-term debt accounts for 19.0% of total debt, cash equals 45.2% of debt, and total debt stands at 269.0bn.

Leverage and liquidity trend

Net Debt / Equity 0.08x +0.21x
Interest Coverage 22.89x +2.06x
Cash / Debt 45.2% −614.9pp
Short-term Debt / Total Debt 19.0% −21.0pp
CFO / NI 1.65x +0.78x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 615.2bn in 2025, against investing cash flow of -661.6bn.

Post-investment cash flow was negative +46.4bn. Financing cash flow was negative +65.0bn.

CFO / net income was 1.65x.

After spending +394.5bn on fixed-asset investment, the business generated trailing free cash flow of +82.9bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 477.4bn +228.0bn
Cash Capex 394.5bn +287.0bn
FCF TTM +82.9bn −59.0bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is earnings conversion is confirmed, with CFO/NI at 1.65x. The main risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 218 days.

Improvement: earnings conversion looks more confirmed, with CFO / net income at 1.65x.

Key risk: working capital remains tied up for too long, with cash cycle at 217.9 days.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
1,865.4 1,727.5 1,651.8 1,554.8 1,558.5
Cost of Goods Sold
981.0 895.0 853.2 787.2 0.0
Gross Profit
884.4 832.6 798.5 767.7 622.6
Financial Expenses
14.6 16.9 17.9 12.0 -8.6
Selling Expenses
418.3 404.2 375.6 357.4 -276.4
General and Administrative Expenses
139.8 122.8 126.0 136.9 -129.0
Operating Profit
349.1 329.1 322.0 298.7 230.9
Profit Before Tax
346.1 325.1 320.1 298.6 232.4
Net Income
291.9 275.2 269.1 243.6 184.1
Profit Attributable to Parent
291.9 275.2 269.1 243.6 184.1
Earnings per Share
2,674.00 2,530.00 3,092.00 2,799.00 3,195.99

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.